Literature DB >> 28975471

Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation.

Sonia Villapol1.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPARγ) has been implicated in the pathology of numerous diseases involving diabetes, stroke, cancer, or obesity. It is expressed in diverse cell types, including vessels, immune and glial cells, and neurons. PPARγ plays crucial roles in the regulation of cellular differentiation, lipid metabolism, or glucose homeostasis. PPARγ ligands also exert effects on attenuating degenerative processes in the brain, as well as in peripheral systems, and it has been associated with the control of anti-inflammatory mechanisms, oxidative stress, neuronal death, neurogenesis, differentiation, and angiogenesis. This review will highlight key advances in the understanding of the PPARγ-related mechanisms responsible for neuroprotection after brain injuries, both ischemia and traumatic brain injury, and it will also cover the natural and synthetic agonist for PPARγ, angiotensin receptor blockers, and PPARγ antagonists, used in experimental and clinical research. A better understanding of the pleiotropic mechanisms and applications of these drugs to improve the recovery and to repair the acute and chronic induced neuroinflammation after brain injuries will pave the way for more effective therapeutic strategies after brain deficits.

Entities:  

Keywords:  Agonist; Angiogenesis; Angiotensin receptor blockers; Brain injury; Inflammation; PPAR gamma

Mesh:

Substances:

Year:  2017        PMID: 28975471      PMCID: PMC5776063          DOI: 10.1007/s10571-017-0554-5

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  124 in total

Review 1.  Modulation of peroxisome proliferator-activated receptor gamma (PPAR γ) by conjugated fatty acid in obesity and inflammatory bowel disease.

Authors:  Gaofeng Yuan; Xiaoe Chen; Duo Li
Journal:  J Agric Food Chem       Date:  2015-02-12       Impact factor: 5.279

2.  Peroxisome proliferator-activated receptor γ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo.

Authors:  Jose A Morales-Garcia; Rosario Luna-Medina; Clara Alfaro-Cervello; Marta Cortes-Canteli; Angel Santos; Jose M Garcia-Verdugo; Ana Perez-Castillo
Journal:  Glia       Date:  2011-02       Impact factor: 7.452

3.  Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.

Authors:  K Yamakawa; M Hosoi; H Koyama; S Tanaka; S Fukumoto; H Morii; Y Nishizawa
Journal:  Biochem Biophys Res Commun       Date:  2000-05-19       Impact factor: 3.575

Review 4.  Implications of the endogenous PPAR-gamma ligand, 15-deoxy-delta-12, 14-prostaglandin J2, in diabetic retinopathy.

Authors:  Tapan Behl; Ishneet Kaur; Heena Goel; Anita Kotwani
Journal:  Life Sci       Date:  2016-04-06       Impact factor: 5.037

5.  Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.

Authors:  Eun Young Park; Il Je Cho; Sang Geon Kim
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

6.  Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia.

Authors:  Lijuan Han; Wei Cai; Leilei Mao; Jia Liu; Peiying Li; Rehana K Leak; Yun Xu; Xiaoming Hu; Jun Chen
Journal:  Stroke       Date:  2015-08-04       Impact factor: 7.914

7.  Pharmacokinetics of rosiglitazone in patients with varying degrees of renal insufficiency.

Authors:  Martha C Chapelsky; Kathleen Thompson-Culkin; Ann K Miller; Marshall Sack; Robert Blum; Martin I Freed
Journal:  J Clin Pharmacol       Date:  2003-03       Impact factor: 3.126

Review 8.  Modulation of immune response by head injury.

Authors:  Maria Cristina Morganti-Kossmann; Laveniya Satgunaseelan; Nicole Bye; Thomas Kossmann
Journal:  Injury       Date:  2007-11-28       Impact factor: 2.586

9.  Effect of pioglitazone on excitotoxic neuronal damage in the mouse hippocampus.

Authors:  Choong Hyun Lee; Min-Hee Yi; Dong Jin Chae; Enji Zhang; Sang-Ha Oh; Dong Woon Kim
Journal:  Biomol Ther (Seoul)       Date:  2015-05-01       Impact factor: 4.634

10.  Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease.

Authors:  Wenjing Luo; Qinyu Xu; Qi Wang; Huimin Wu; Jing Hua
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

View more
  78 in total

Review 1.  Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease.

Authors:  Nicholas F Fitz; Kyong Nyon Nam; Radosveta Koldamova; Iliya Lefterov
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

Review 2.  Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.

Authors:  Nilson Carlos Ferreira Junior; Maurício Dos-Santos-Pereira; Francisco Silveira Guimarães; Elaine Del Bel
Journal:  Neurotox Res       Date:  2019-10-22       Impact factor: 3.911

Review 3.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

4.  Ibuprofen does not inhibit RhoA-mediated growth cone collapse of embryonic chicken retinal axons by LPA.

Authors:  James Vinton; Adaeze Aninweze; Eric Birgbauer
Journal:  Exp Brain Res       Date:  2021-07-28       Impact factor: 1.972

5.  β4GalT1 Mediates PPARγ N-Glycosylation to Attenuate Microglia Inflammatory Activation.

Authors:  Xiaojuan Liu; Aihong Li; Yuanyuan Ju; Wangrui Liu; Hui Shi; Renyue Hu; Zijian Zhou; Xiaolei Sun
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

6.  Activation of peroxisome proliferator-activated receptor γ reduces alcohol drinking and seeking by modulating multiple mesocorticolimbic regions in rats.

Authors:  Yannick Fotio; Anna Maria Borruto; Federica Benvenuti; Gregory Demopulos; George Gaitanaris; Marisa Roberto; Roberto Ciccocioppo
Journal:  Neuropsychopharmacology       Date:  2020-07-01       Impact factor: 7.853

Review 7.  The role of PPARγ in chemotherapy-evoked pain.

Authors:  Iryna A Khasabova; Virginia S Seybold; Donald A Simone
Journal:  Neurosci Lett       Date:  2021-03-24       Impact factor: 3.046

Review 8.  Cannabinoids and the expanded endocannabinoid system in neurological disorders.

Authors:  Luigia Cristino; Tiziana Bisogno; Vincenzo Di Marzo
Journal:  Nat Rev Neurol       Date:  2019-12-12       Impact factor: 42.937

Review 9.  Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury.

Authors:  Ashi Mannan; Nikhil Garg; Thakur Gurjeet Singh; Harmeet Kaur Kang
Journal:  Neurochem Res       Date:  2021-07-20       Impact factor: 3.996

10.  Peripheral-to-central immune communication at the area postrema glial-barrier following bleomycin-induced sterile lung injury in adult rats.

Authors:  David G Litvin; Scott J Denstaedt; Lauren F Borkowski; Nicole L Nichols; Thomas E Dick; Corey B Smith; Frank J Jacono
Journal:  Brain Behav Immun       Date:  2020-02-22       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.